AG000L9E

123948-87-8 | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-

Chemical structure of 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-, CAS 123948-87-8
AG000L9E
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 123948-87-8
Catalog Number AG000L9E(AGN-PC-0PHPJA)
Chemical Name 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-
IUPAC Name (19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
InChI InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1
InChI Key UCFGDBYHRUNTLO-QHCPKHFHSA-N
MDL Number MFCD00870670
Molecular Formula C23H23N3O5
Molecular Weight 421.4458
NSC Number 641007
SMILES O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=CC5=C(CN(C)C)C(O)=CC=C5N=C4C3=C2)=O
UNII 7M7YKX2N15
Synonyms
9 Dimethylaminomethyl 10 hydroxycamptothecin, 9-Dimethylaminomethyl-10-hydroxycamptothecin, Hycamtamine, Hycamtin, Hydrochloride, Nogitecan, Hydrochloride, Topotecan, Nogitecan Hydrochloride, NSC 609699, NSC-609699, NSC609699, SK and F 104864 A, SK and F-104864-A, SK and F104864A, SKF 104864 A, SKF-104864-A, SKF104864A, Topotecan, Topotecan Hydrochloride, Topotecan Monohydrochloride, (S)-Isomer, topotecan, 123948-87-8, Hycamtin, Topotecan lactone, Hycamptamine, Topotecane, Topotecanum, Hycamtamine, Topotecane [INN-French], Topotecanum [INN-Latin], (S)-Topotecan, Hycamptin, Topotecan [INN:BAN], SKF-104864-A, SK&F-104864-A, 9-Dimethylaminomethyl-10-hydroxycamptothecin, UNII-7M7YKX2N15, C23H23N3O5, CHEMBL84, NSC609699, Hycamtin (TN), 7M7YKX2N15, CHEBI:63632, SK-S-104864-A, (4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, (S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE, Nogitecan, 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-, 9-[(dimethylamino)methyl]-10-hydroxy-(4S)-camptothecin, CHEMBL1607, Topophore C, Topotecan Actavis, TopoCED, Topotecan (BAN), (S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione, (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-, (S)-, SK&F-S-104864A, SR-01000763672, TOPOTECAN, HYCAMTIN, SK&F 104864 A, 9-Dimethylaminomethyl-10-hydroxycamptothecin., Topotecan Monohydrochloride, (S)-Isomer, CCRIS 8163, MFCD00870670, HSDB 8213, 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (S)-, SKF-S 104864, SKF 104864, AC1L1TQZ, AC1Q6APZ, SCHEMBL3836, NCIStruc1_001659, NCIStruc2_001796, BSPBio_002348, cid_60699, GTPL7101, DTXSID3042685, KS-00000PLT, EX-A834, UCFGDBYHRUNTLO-QHCPKHFHSA-N, HMS2090B20, HMS3715L03, ZINC1611274, BDBM50008935, BDBM50034026, HSCI1_000228, NSC641007, AKOS015966792, API0004452, AT-2921, CCG-221171, CS-2887, DB01030, NSC-641007, SMP2_000312, SMP2_000327, NCGC00014925-02, NCGC00014925-03, NCGC00014925-04, NCGC00014925-07, NCGC00014925-10, NCGC00178695-01, (S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione, AC-11592, AJ-90579, AK-72818, AN-32741, CC-35105, HY-13768, M965, NCI60_004771, AB0015476, AX8224399, LS-127395, B4982, dimethylaminomethyl-ethyl-dihydroxy-[?]dione, FT-0654504, ST24026008, ST24031920, T-161, A16815, C11158, D08618, W-1887, AB00641837-09, AB00641837-11, AB00641837-12, AB00641837-13, AB00641837-14, AB00641837_15, AB00641837_16, 948T878, C-22083, SR-01000763672-3, SR-01000763672-4, BRD-K55696337-001-03-2, BRD-K55696337-003-08-7, Topotecan hydrochloride hydrate, >=98% (HPLC and enzymatic), (19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0;{2,11}.0;{4,9}.0;{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione, (20S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, (4-Ethyl-4,9-dihydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-10-ylmethyl)-dimethyl-ammonium, (alphaS)-alpha,8-Dihydroxy-1(11H)-oxo-alpha-ethyl-2-(hydroxymethyl)-9-(dimethylaminomethyl)-5,11a-diaza-11aH-benzo[b]fluorene-3-acetic acid 3,2-lactone, (alphaS)-alpha-Hydroxy-8-oxylato-1(11H)-oxo-alpha-ethyl-2-(hydroxymethyl)-9-(dimethylaminiomethyl)-5,11a-diaza-11aH-benzo[b]fluorene-3-acetic acid 3,2-lactone, (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3'''',4'''':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE, (S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, (S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride, (S)-11-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, (S)-11-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride, 10-dimethylaminomethyl-4-ethyl-4,9-dihydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'''',4'''':6,7]indolizino[1,2-b]quinoline-3,14-dione, 10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, 10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (Topotecan), 10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione(Topotecan), 10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride, 1H-Pyrano[3',7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-, Topotecan Hcl, potactasol, nogitecan HCl, Topotecan SUN, Topotecan Hospira, TOPOTECAN HYDROCHLORIDE, Nogitecan hydrochloride, Hydrochloride, Nogitecan, Hydrochloride, Topotecan, D02PMO, NSC 609699, SKF104864A, NSC-609699, CID60700, SK&F104864A, SK&F S-104864-A, SKF 104864 A, C23-H23-N3-O5, ACN-057092, CS-O-02414, 1749B, 9 Dimethylaminomethyl 10 hydroxycamptothecin, D019772, 119413-54-6, 9-[(dimethylamino)methyl]-10-hydroxy-(20S)-camptothecin, TTC, TPT, 4-Ethyl-4,9-dihydroxy-10-[(dimethylamino)methyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited